major depressive disorder
Novartis halts depression drug trial, putting $210M Cadent buyout at risk
Anika Sharma
Novartis has made the decision to discontinue a mid-phase program aimed at treating major depressive disorder (MDD) with the investigational ...
Motif Neurotech implants tiny device to stimulate brain and treat depression
Anika Sharma
Neurostimulation has emerged as a promising therapy for alleviating the symptoms of major depressive disorder, even in cases where traditional ...
Sage slashes 40% of staff, reshuffles leadership after zuranolone setback
Anika Sharma
Sage Therapeutics is set to undergo a significant transformation by reducing its workforce by 40% following a setback in gaining ...
